Tags

Type your tag names separated by a space and hit enter

Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease

Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

"Anti-cholinergic Bronchodilators Versus Beta2-sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease.
Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease. Accessed August 21, 2019.
Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease
Anti-cholinergic Bronchodilators Versus Beta2-sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 August 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease ID - 450367 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -